Salvatore Calabrese

Salvatore Calabrese formerly worked at AGC Biologics SpA, as Chief Financial Officer & Director-Administration from 2018 to 2020, Jazz Pharmaceuticals Italy SRL, as Director, Jazz Healthcare Italy Srl, as Director, Gentium Srl, as COO, CFO, Senior VP & Head-Investor Relations from 2013 to 2014, Novuspharma SpA, as Manager-Accounting & Finance in 2005, PricewaterhouseCoopers SpA, as Manager-Assurance Business Advisory Services in 2003, and Gain Therapeutics, Inc., as Chief Financial Officer from 2022 to 2023.
Mr. Calabrese received his graduate degree from the University of Pavia and undergraduate degree from the University of Messina.